Swedish Orphan Financials
| SOBI Stock | SEK 317.00 2.60 0.83% |
Swedish |
Please note, the imprecision that can be found in Swedish Orphan's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Swedish Orphan Biovitrum. Check Swedish Orphan's Beneish M Score to see the likelihood of Swedish Orphan's management manipulating its earnings.
Swedish Orphan Stock Summary
Swedish Orphan competes with Getinge AB, Elekta AB, AB SKF, Saab AB, and Essity AB. Swedish Orphan Biovitrum AB , an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, immunology, and genetic and metabolic diseases. Swedish Orphan Biovitrum AB is headquartered in Solna, Sweden. Swedish Orphan operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 1185 people.| Foreign Associate | USA |
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0000872095 |
| Business Address | Tomtebodavgen 23A, Solna, |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.sobi.com |
| Phone | 46 86 97 20 00 |
| Currency | SEK - Swedish Kronor |
You should never invest in Swedish Orphan without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Swedish Stock, because this is throwing your money away. Analyzing the key information contained in Swedish Orphan's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Swedish Orphan Key Financial Ratios
Swedish Orphan's financial ratios allow both analysts and investors to convert raw data from Swedish Orphan's financial statements into concise, actionable information that can be used to evaluate the performance of Swedish Orphan over time and compare it to other companies across industries.| Return On Equity | 0.11 | |||
| Return On Asset | 0.0555 | |||
| Target Price | 269.56 | |||
| Beta | 0.39 | |||
| Z Score | 4.8 |
Swedish Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Swedish Orphan's current stock value. Our valuation model uses many indicators to compare Swedish Orphan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Swedish Orphan competition to find correlations between indicators driving Swedish Orphan's intrinsic value. More Info.Swedish Orphan Biovitrum is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Swedish Orphan Biovitrum is roughly 1.91 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Swedish Orphan's earnings, one of the primary drivers of an investment's value.Swedish Orphan Biovitrum Systematic Risk
Swedish Orphan's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Swedish Orphan volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Swedish Orphan Biovitrum correlated with the market. If Beta is less than 0 Swedish Orphan generally moves in the opposite direction as compared to the market. If Swedish Orphan Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Swedish Orphan Biovitrum is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Swedish Orphan is generally in the same direction as the market. If Beta > 1 Swedish Orphan moves generally in the same direction as, but more than the movement of the benchmark.
Swedish Orphan December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Swedish Orphan help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Swedish Orphan Biovitrum. We use our internally-developed statistical techniques to arrive at the intrinsic value of Swedish Orphan Biovitrum based on widely used predictive technical indicators. In general, we focus on analyzing Swedish Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Swedish Orphan's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.66 | |||
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 15.62 | |||
| Value At Risk | (2.68) | |||
| Potential Upside | 2.79 |
Additional Tools for Swedish Stock Analysis
When running Swedish Orphan's price analysis, check to measure Swedish Orphan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Swedish Orphan is operating at the current time. Most of Swedish Orphan's value examination focuses on studying past and present price action to predict the probability of Swedish Orphan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Swedish Orphan's price. Additionally, you may evaluate how the addition of Swedish Orphan to your portfolios can decrease your overall portfolio volatility.